Mark Froimson

Insider Reports History

Location
Tampa, FL
Signature
/s/ Kristen Williams, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Froimson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Pacira BioSciences, Inc. Director Common Stock 20,636 $518,376 $25.12 11 Jun 2025 Direct
Pacira BioSciences, Inc. Director Stock Option (Right to Buy) 11,279 $323,840 $26.59 11 Jun 2025 Direct

Insider Reports Filed by Mark Froimson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PCRX Pacira BioSciences, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:18
PCRX Pacira BioSciences, Inc. 12 Aug 2024 1 +$16,212 4 Director 12 Aug 2024, 20:33
PCRX Pacira BioSciences, Inc. 12 Jun 2024 2 $0 4 Director 13 Jun 2024, 18:13
PCRX Pacira BioSciences, Inc. 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 17:30
PCRX Pacira BioSciences, Inc. 06 Jun 2022 2 $0 4 Director 08 Jun 2022, 19:22
PCRX Pacira BioSciences, Inc. 09 May 2022 1 -$59,370 4 Director 11 May 2022, 16:13
PCRX Pacira BioSciences, Inc. 17 Dec 2021 1 $0 4 Director 20 Dec 2021, 15:13
PCRX Pacira BioSciences, Inc. 09 Jun 2021 2 $0 4 Director 11 Jun 2021, 20:32